Innovations in Drug Delivery Methods
Patient-centric innovation is a major trend in the Erythropoietin Drugs Market. Traditional hospital-based administration is giving way to self-injection options via autoinjectors and prefilled syringes. These advancements reduce patient travel and hospital visits, improving adherence to treatment schedules.
Some manufacturers are exploring long-acting formulations to reduce dosing frequency, which can enhance patient comfort and convenience. As digital health tools integrate with drug delivery devices, remote monitoring of patient outcomes may further improve personalized anemia management.
3 Views